Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 140.23
Day High 142.50
Open:142.10
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Trailing Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Global Antihistamines Market to 2026 - Key Players are Bayer, Almirall, Johnson & Johnson, AstraZeneca, Novartis, Pfizer, Sanofi, Boehringer Ingelheim, Merck & Co, Akorn & Teva
PR Newswire - Mon Sep 24, 8:00AM CDT
PR Newswire - CMTX
Mon Sep 24, 8:00AM CDT
https://mma.prnewswire.com/media/732750/Research_and_Markets.jpg
Evarrest (Johnson & Johnson) 2017-2018 U.S. Promotional Audit Report - ResearchAndMarkets.com
BusinessWire - Mon Sep 24, 6:18AM CDT
BusinessWire - CMTX
Mon Sep 24, 6:18AM CDT
The "Evarrest 2017 U.S. Promotional Audit Report" report has been added to ResearchAndMarkets.com's offering.
Janssen Announces Results of Esketamine Nasal Spray Phase 3 Study in Patients with Treatment-Resistant Depression
PR Newswire - Fri Sep 21, 5:00PM CDT
PR Newswire - CMTX
Fri Sep 21, 5:00PM CDT
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from a Phase 3 clinical study of the investigational product esketamine nasal spray in patients with treatment-resistant depression. Janssen researchers presented these results at the Ninth Biennial Conference of the International Society for Affective Disorders (ISAD) and the Houston Mood Disorders Conference, taking place September 20-22, 2018 in Houston, TX.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 133.44 +5.27% increase
on 09/04/18
Period Open:135.95
Price movement based on the high, low and last over the given period.
143.13 -1.86% decrease
on 09/21/18
+4.52 (+3.32%) increase
since 08/24/18
3-Month 120.11 +16.95% increase
on 07/02/18
Period Open:122.84
Price movement based on the high, low and last over the given period.
143.13 -1.86% decrease
on 09/21/18
+17.63 (+14.35%) increase
since 06/22/18
52-Week 118.62 +18.42% increase
on 05/29/18
Period Open:131.39
Price movement based on the high, low and last over the given period.
148.32 -5.29% decrease
on 01/17/18
+9.08 (+6.91%) increase
since 09/22/17

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement